摘要 |
Pharmaceutical compositions comprising an anti-emetic compound and a highly orally bioavailable form of propofol, oral dosage forms comprising an anti-emetic compound and a highly orally bioavailable form of propofol and methods of treating emesis in a patient comprising orally administering a therapeutically effective amount of an anti-emetic compound and a highly orally bioavailable form of propofol are disclosed.
|